Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The essential role of dermatology publications in enhancing professional diversity, equity, and inclusion.

Clinics in dermatology·2022
Same author

The essential role of dermatology publications in enhancing professional diversity, equity and inclusion.

The British journal of dermatology·2021
Same author

Dermatological education for the 21st century: prioritizing diversity.

The British journal of dermatology·2020
Same author

The polypeptide composition of epidermal prekeratin.

Biochimica et biophysica acta·2009
Same author

What is the pathogenesis of acne?

Experimental dermatology·2005
Same author

What is the 'true' function of skin?

Experimental dermatology·2002
Same journal

An Integrated Skin Cell Atlas Decodes the Pilosebaceous Unit.

The Journal of investigative dermatology·2026
Same journal

Residual CSB activity explains mild UV-sensitive syndrome phenotype caused by CSB mutations.

The Journal of investigative dermatology·2026
Same journal

Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts.

The Journal of investigative dermatology·2026
Same journal

Human keratinocytes and fibroblasts coordinate early cutaneous innate defenses against Candida auris.

The Journal of investigative dermatology·2026
Same journal

Merkel cells attenuate autoantigen-specific T cell driven skin inflammation in mice associated with reduced neutrophil recruitment.

The Journal of investigative dermatology·2026
Same journal

The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

The Journal of investigative dermatology·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Human epidermal transglutaminase.

L A Goldsmith1

  • 1Dermatology Unit, University of Rochester School of Medicine and Dentistry, Rochester, New York, U.S.A.

The Journal of Investigative Dermatology
|May 19, 2010
PubMed
Summary
This summary is machine-generated.

Epidermal transglutaminase is crucial for skin cell differentiation. Researchers found that solvents and chemicals can increase its activity, suggesting potential treatments for skin diseases.

More Related Videos

Three-dimensional Inflammatory Human Tissue Equivalents of Gingiva
08:43

Three-dimensional Inflammatory Human Tissue Equivalents of Gingiva

Published on: April 3, 2018

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
08:49

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

Related Experiment Videos

Last Updated: Jun 13, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Three-dimensional Inflammatory Human Tissue Equivalents of Gingiva
08:43

Three-dimensional Inflammatory Human Tissue Equivalents of Gingiva

Published on: April 3, 2018

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
08:49

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

Area of Science:

  • Biochemistry
  • Dermatology
  • Enzymology

Background:

  • Epidermal transglutaminase (eTG) plays a vital role in epidermal terminal differentiation.
  • Understanding eTG's activity control is crucial due to its irreversible catalytic function.
  • eTG requires calcium and a free sulfhydryl group, unlike some other transglutaminases.

Purpose of the Study:

  • Investigate the structural consequences and activity modulation of epidermal transglutaminase.
  • Explore the effects of various agents on eTG activity and structure.
  • Develop methods for in vivo modulation of eTG for treating epidermal diseases.

Main Methods:

  • Purification and characterization of human epidermal transglutaminase.
  • Treatment of purified eTG with organic solvents, heat, calcium, and chaotropic reagents.
  • Analysis of enzyme activity changes using gel-filtration and SDS-electrophoresis.
  • Development of monoclonal antibodies for detailed structural and antigenic site analysis.

Main Results:

  • Purified eTG activity increased significantly after treatment with organic solvents (e.g., DMSO), heat, and chaotropic agents (NaSCN, NaI).
  • Enhanced activity correlated with altered gel-filtration characteristics but not major molecular weight changes (SDS-electrophoresis) or immunologic differences.
  • Antibodies to eTG showed high species specificity and no cross-reactivity with hair follicle transglutaminase.

Conclusions:

  • Solvents, chemicals, and drugs can alter epidermal transglutaminase function.
  • This modulation offers potential for safe in vivo therapeutic strategies for epidermal diseases.
  • Further research with monoclonal antibodies will aid in understanding eTG structural activation and common antigenic sites.